Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 507334036 series 3393216
Content provided by Baptist Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Baptist Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts:
Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute.
From precision-targeted therapies and measurable residual disease (MRD) to cutting-edge immunotherapies like (CAR) T-cell therapy, BiTEs, and NK-cell approaches — we cover the evolving tools that are reshaping treatment protocols across leukemia, myeloma, MDS, and lymphoma.
Topics Covered:
✅ MRD-guided treatment decisions
✅ Overcoming drug resistance with combination strategies
✅ Targeted therapies for actionable mutations
✅ The expanding role of CAR T, BiTEs, and NK cells
✅ Clinical application and access at Baptist Health
If you're an oncologist, hematologist, or transplant specialist navigating the complexity of hematologic malignancies — this conversation will help sharpen your clinical edge.
🔔 Subscribe for more expert insights: @BaptistHealthSF
📍 Learn more at MiamiCancerInstitute.com
33 episodes
